Increasing Gene Therapies Drive Growth In Viral Vectors And Plasmid DNA Manufacturing Market: Major Factor in the Transformation of the Viral Vectors And Plasmid DNA Manufacturing Market in 2025

How Will the Viral Vectors And Plasmid DNA Manufacturing Market Grow, and What Is the Projected Market Size?_x000D_
In recent years, the market for viral vectors and plasmid DNA manufacturing has seen a significant expansion. The market, which was valued at $5.75 billion in 2024, anticipates a swell to $7.11 billion in 2025, illustrating a compound annual growth rate (CAGR) of 23.8%. Factors such as the rising demand for personalized medicine, advancements in vaccine development, the availability of funding for gene therapy development, the efficiency of viral vectors in gene therapy delivery, and their potential applications in innovative drug delivery methods have contributed to the growth experienced during the historic period._x000D_
_x000D_
The market for viral vectors and plasmid DNA manufacturing is projected to undergo significant expansion in the following years, reaching $16.52 billion in 2029 with a 23.5% Compound Annual Growth Rate (CAGR). This predicted growth during the forecast period could be due to the rising number of gene therapies, an increasing number of market participants, higher prevalence of infectious diseases and genetic disorders, growing investments into cell and gene therapy research, and a rising incidence of targeted disorders and diseases. Foreseen trends during this period encompass advancements in technology and gene therapy, the adoption of cutting-edge technologies and single-use technologies, and progress in vaccine technology._x000D_
_x000D_
What Key Elements Are Boosting Growth in the Viral Vectors And Plasmid DNA Manufacturing Market?_x000D_
The growth of the viral vectors and plasmid DNA manufacturing market is anticipated to be spurred by the rising number of gene therapies. Gene therapy refers to the process of introducing, altering, or eliminating genetic material within an individual's cells to combat or prevent a disease. The development of gene therapy is crucial due to the increasing investment in biotechnology research and development, coupled with a more in-depth understanding of genetic and cellular mechanisms related to various diseases. Manufacture of viral vectors and plasmid DNA plays a crucial role by enabling the delivery of therapeutic genes into the cells of patients, thus treating genetic disorders at their molecular level. For instance, the American Society of Gene & Cell Therapy, a non-profit medical and scientific organization based in the US, reported a 10% growth in gene therapies in Phase III clinical trials in Q3 2023, marking the first quarterly increase since Q3 2022. Consequently, the growing number of gene therapies is fueling the expansion of the viral vectors and plasmid DNA manufacturing market._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=20690&type=smp_x000D_
_x000D_
Who Are the Major Industry Players Fueling Viral Vectors And Plasmid DNA Manufacturing Market Expansion?_x000D_
Major companies operating in the viral vectors and plasmid DNA manufacturing market are Merck KGaA, Thermo Fisher Scientific Inc., Astellas Pharma Inc., Lonza Group AG, Catalent Inc., Revvity Inc., Wuxi Biologics Inc., BioMarin Pharmaceutical, FUJIFILM Diosynth Biotechnologies, Miltenyi Biotec GmbH, Aldevron LLC, Takara Bio Inc., Poseida Therapeutics Inc., RegenxBio Inc., Cobra Biologics, Finvector Vision Therapies Limited, Batavia Biosciences B.V., uniQure N.V., Addgene Inc., BioNTech IMFS GmbH, Creative Biogene Inc., Genezen Laboratories Inc., Virovek Incorporation, Waisman Biomanufacturing, Axplora GmbH _x000D_
_x000D_
Who Are the Major Industry Players Fueling Market Expansion?_x000D_
Key players in the viral vectors and plasmid DNA manufacturing market are leveraging strategic alliances to boost their production capabilities, advance their technological prowess, and hasten the global development and launch of gene therapies. These partnerships allow firms to pool resources and infrastructure, thereby augmenting manufacturing capacity to cater to the rising demand for gene therapies. For example, in June 2024, preclinical and clinical contract research organization Charles River Laboratories International Inc. in the USA and Captain T Cell, an offshoot of the widely recognized Max Delbrück Center, Berlin, Germany, initiated a partnership for plasmid DNA and retrovirus vector production. This association grants Captain T Cell admittance to firmly rooted contract development and manufacturing (CDMO) expertise and consulting services. It also aims to expedite the transition from preclinical research to clinical trials for a unique TCR-T cell therapy targeting solid tumors._x000D_
_x000D_
How Is the Segmentation of the Viral Vectors And Plasmid DNA Manufacturing Market Defined?_x000D_
The viral vectors and plasmid dna manufacturing market covered in this report is segmented - _x000D_
_x000D_
1) By Product Type: Plasmid Deoxyribonucleic Acid (DNA), Viral Vector, Non-Viral Vector_x000D_
2) By Scale Of Operation: Preclinical, Clinical, Commercial_x000D_
3) By Therapeutic Area: Oncological Disorders, Rare Diseases, Neurological Disorders, Sensory Disorders, Metabolic Disorders, Musculoskeletal Disorders, Blood Disorders, Immunological Disorders, Other Disorders_x000D_
4) By Application Area: Gene Therapies, Cell Therapies, Vaccines_x000D_
5) By Type Of Manufacturer: In-house Manufacturers, Contract Manufacturing Organizations_x000D_
_x000D_
Subsegments:_x000D_
1) By Plasmid Deoxyribonucleic Acid (DNA): Linear Plasmid DNA, Circular Plasmid DNA, High-Copy Plasmid DNA, Low-Copy Plasmid DNA _x000D_
2) By Viral Vector: Adenoviral Vectors, Lentiviral Vectors, Adeno-Associated Viral Vectors (AAV), Retroviral Vectors _x000D_
3) By Non-Viral Vector: Liposome-Based Vectors, Polymer-Based Vectors, Nanoparticle-Based Vectors, Electroporation-Based Vectors _x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-manufacturing-global-market-report_x000D_
_x000D_
What Is the Leading Region in the Viral Vectors And Plasmid DNA Manufacturing Market?_x000D_
North America was the largest region in the viral vectors and plasmid DNA manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vectors and plasmid DNA manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Viral Vectors And Plasmid DNA Manufacturing Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the viral vectors and plasmid dna manufacturing Market Size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the viral vectors and plasmid dna manufacturing market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall viral vectors and plasmid dna manufacturing market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the viral vectors and plasmid dna manufacturing market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20690_x000D_
_x000D_

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.